PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34203709-2	2021	Multiple receptor tyrosine kinase (RTK) pathways contribute to the resistance of NSCLC to first- and third-generation EGFR-TKIs, such as erlotinib and osimertinib.	osimertinib	151-162	ret proto-oncogene	Homo sapiens	9-33	
34203709-2	2021	Multiple receptor tyrosine kinase (RTK) pathways contribute to the resistance of NSCLC to first- and third-generation EGFR-TKIs, such as erlotinib and osimertinib.	osimertinib	151-162	ret proto-oncogene	Homo sapiens	35-38